Parkman Healthcare Partners LLC 13D and 13G filings for Plus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 3:25 pm Sale |
2022-12-31 | 13G | Plus Therapeutics, Inc. PSTV |
Parkman Healthcare Partners LLC | 38,898 1.700% |
-61,669 (-61.32%) |
Filing |
| 2022-02-04 5:00 pm Purchase |
2022-01-28 | 13G | Plus Therapeutics, Inc. PSTV |
Parkman Healthcare Partners LLC | 100,567 7.400% |
100,567 (New Position) |
Filing |